Vol 10-3 Commentary and Opinion Article

Psychogenic Nonepileptic Seizures Emerging in Established Epilepsy: A Clinical Perspective

Reecha Khadka1*, Gita Limbu2, Ghanshyam Kharel3

1Department of Clinical Psychology, Upendra Devkota Memorial National Institute of Neurological and Allied Sciences, Kathmandu, Nepal

2Department of Clinical Psychology, Nepal Mediciti Hospital, Kathmandu, Nepal

3Department of Neurology, Upendra Devkota Memorial National Institute of Neurological and Allied Sciences, Kathmandu, Nepal

Psychogenic nonepileptic seizures (PNES) are increasingly recognized as a condition that can coexist with established epilepsy and may emerge after an epilepsy diagnosis. This perspective draws on clinical observations from five patients with neurologist-confirmed epilepsy who subsequently developed additional seizure-like episodes clinically diagnosed as PNES. These observations are used to explore why this dual presentation may be overlooked during routine neurological follow-up. Across these observations, a recurrent pattern emerged: a change in seizure semiology, reduced or absent postictal confusion, a temporal association with psychosocial stressors, and an absence of epileptiform abnormalities on routine electroencephalography (EEG). These findings prompted further clinical assessment but did not independently establish PNES. Building on theoretical models involving fear conditioning, illness behaviour reinforcement, and cumulative psychosocial burden, as well as the diagnostic “borderland” between neurology and psychiatry, this article proposes a practical framework of clinical indicators that may raise suspicion of emergent PNES and prompt further assessment. The discussion is further situated within the Nepalese context, where a wide epilepsy treatment gap, limited video-EEG capacity, and pervasive stigma around both seizure disorders and mental illness make this dual presentation especially likely to be overlooked. Earlier recognition may reduce unnecessary escalation of antiepileptic medication and support timelier referral for psychological assessment and treatment.

DOI: 10.29245/2578-2959/2026/3.1380 View / Download Pdf
Vol 10-3 Review of Literature

Anxiety: The Use of Sensorial Stimulation in Relation to Mind-Body Awareness and Techniques (Sensory Modulation) in Day-To-Day Symptom Management of Anxiety

Katelynd Campo

Criminologist, Canada

Anxiety is commonly experienced by all individuals around the world one way or another. Experienced symptoms of anxiety often includes corporal bodily sensations and/or ruminating and intrusive thoughts following maladaptive cognitions towards an undesired event or trigger. Cognitive distortions can potentiate and provoke feelings of uneasiness and ambivalence, making it harder to function and/or concentrate on day-to-day tasks. There exists a number of symptom management techniques and coping strategies wherein anxiety is concerned, however the field of sensorial items/devices in anxiety management lacks in investigation and attention wherein anxiety, mind-body awareness, and multisensory experience in emotional regulation is concerned. The use of sensorial items/devices in support of enabling greater mind-body awareness and grounding deserves greater attention to be brought towards their use in anxiety symptom management outside of the counselling session.

DOI: 10.29245/2578-2959/2026/3.1371 View / Download Pdf
Vol 10-3 Mini Review Article

Semaglutide and Drug Craving: Emerging Perspectives in Addiction Psychiatry

Vincenzo Maria Romeo1,2,3

1Department of Cultures and Societies, University of Palermo, Palermo, Italy

2School of Psychoanalytic and Groupanalytic Psychotherapy (SPPG), Reggio Calabria, Italy

3Neurosinc, Catania, Italy

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes and obesity, has attracted interest as a potential modulator of drug craving and substance-related reinforcement. This mini-review examines mechanistic and clinical evidence across cocaine, alcohol, nicotine, and opioid use disorders. Preclinical studies implicate mesolimbic GLP-1 signalling in reward, cue reactivity, and consummatory behaviour. Human evidence remains limited but is most persuasive for alcohol use disorder, where randomized subcutaneous and oral semaglutide trials have reported improvements in selected drinking and craving outcomes; evidence for cocaine and nicotine remains preliminary or mixed, and opioid evidence is largely observational or protocol-level. A central interpretative challenge is whether apparent benefits reflect direct reward modulation or indirect effects of appetite suppression, gastrointestinal symptoms, weight loss, or metabolic improvement. Semaglutide is not an established pharmacotherapy for substance use disorders, and approved metabolic indications must remain distinct from investigational anti-craving use. Further trials should use substance-specific clinical outcomes, objective measures of consumption, formal mediation analyses, representative psychiatric populations, and longer follow-up.

DOI: 10.29245/2578-2959/2026/3.1378 View / Download Pdf
Vol 10-3 Mini Review Article

Timing Matters: Longitudinal Insights into Emotion Regulation Following Life Stress in Adolescence

Yuri-Grace B. Ohashi1*, Katie Oshins2, Naomi G. Daniel1,2

1Department of Psychology, Harvard University, Cambridge, MA, USA

2Department of Psychology, Northeastern University, Boston, MA, USA

Adolescence is a period of heightened vulnerability to anxiety and depression, with stressful life events as a robust risk factor for internalizing psychopathology. However, heterogeneity in adolescents' responses to stress suggests that emotion regulation (ER) is a key mechanism underlying vulnerability and resilience. In this mini narrative review, we synthesize evidence linking life stress, ER, and internalizing psychopathology, highlighting rumination as the most consistently supported transdiagnostic risk factor while discussing the growing emphasis on ER flexibility. We then examine how longitudinal methods spanning years, months, and moments have advanced understanding of regulatory processes by addressing complementary questions about developmental trajectories, within-person change, and real-time emotional responses to stress. Finally, we discuss how integrating findings across timescales can inform more precise developmental models and personalized interventions for adolescent internalizing psychopathology. Ultimately, we emphasize that understanding ER and the roles strategies may play in connecting life stress to psychopathology requires matching theoretical questions to the temporal scale at which these processes are expected to unfold.

DOI: 10.29245/2578-2959/2026/3.1375 View / Download Pdf
Vol 10-2 Mini Review Article

Income, Employment, and Insurance Gaps After the Onset of Mental Health Disability

Robert Millard

Assistant Professor, Department of Economics, Stony Brook University, Stony Brook, New York, USA

This mini-review examines Millard1, which links Canadian longitudinal survey data to administrative tax records to estimate the economic consequences of disability onset, focusing here on mental health related disabilities. Following onset, earnings fall by roughly $5,800 per year in the short run (1 to 5 years) and $8,400 in the long run (6 to 10 years), with labour force participation declining about 10 percentage points. Government transfers show no statistically significant response and the earnings of other household members do not adjust, so the combined tax and transfer system offsets only about 25 to 33 percent of the income loss and disposable income remains depressed a decade later. As the main paper shows, mental health disability is insured less completely than the other disability types it considers, marking it as among the least insured shocks and pointing to meaningful gaps in coverage.

DOI: 10.29245/2578-2959/2026/2.1376 View / Download Pdf